Literature DB >> 19286555

A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis.

Giuseppe Di Fede1, Marcella Catania, Michela Morbin, Giacomina Rossi, Silvia Suardi, Giulia Mazzoleni, Marco Merlin, Anna Rita Giovagnoli, Sara Prioni, Alessandra Erbetta, Chiara Falcone, Marco Gobbi, Laura Colombo, Antonio Bastone, Marten Beeg, Claudia Manzoni, Bruna Francescucci, Alberto Spagnoli, Laura Cantù, Elena Del Favero, Efrat Levy, Mario Salmona, Fabrizio Tagliavini.   

Abstract

beta-Amyloid precursor protein (APP) mutations cause familial Alzheimer's disease with nearly complete penetrance. We found an APP mutation [alanine-673-->valine-673 (A673V)] that causes disease only in the homozygous state, whereas heterozygous carriers were unaffected, consistent with a recessive Mendelian trait of inheritance. The A673V mutation affected APP processing, resulting in enhanced beta-amyloid (Abeta) production and formation of amyloid fibrils in vitro. Co-incubation of mutated and wild-type peptides conferred instability on Abeta aggregates and inhibited amyloidogenesis and neurotoxicity. The highly amyloidogenic effect of the A673V mutation in the homozygous state and its anti-amyloidogenic effect in the heterozygous state account for the autosomal recessive pattern of inheritance and have implications for genetic screening and the potential treatment of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286555      PMCID: PMC2728497          DOI: 10.1126/science.1168979

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  18 in total

Review 1.  Molecular genetics of Alzheimer's disease.

Authors:  P H St George-Hyslop
Journal:  Biol Psychiatry       Date:  2000-02-01       Impact factor: 13.382

2.  Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Authors:  Dominic M Walsh; Igor Klyubin; Julia V Fadeeva; William K Cullen; Roger Anwyl; Michael S Wolfe; Michael J Rowan; Dennis J Selkoe
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

3.  Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis.

Authors:  Angela D Williams; Erik Portelius; Indu Kheterpal; Jun-tao Guo; Kelsey D Cook; Ying Xu; Ronald Wetzel
Journal:  J Mol Biol       Date:  2004-01-16       Impact factor: 5.469

4.  Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.

Authors:  Frédérique Bard; Robin Barbour; Catherine Cannon; Robert Carretto; Michael Fox; Dora Games; Teresa Guido; Kathleen Hoenow; Kang Hu; Kelly Johnson-Wood; Karen Khan; Dora Kholodenko; Celeste Lee; Mike Lee; Ruth Motter; Minh Nguyen; Amanda Reed; Dale Schenk; Pearl Tang; Nicki Vasquez; Peter Seubert; Ted Yednock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-03       Impact factor: 11.205

5.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

Authors:  E Levy; M D Carman; I J Fernandez-Madrid; M D Power; I Lieberburg; S G van Duinen; G T Bots; W Luyendijk; B Frangione
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

Review 6.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

7.  Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease.

Authors:  Céline Adessi; Marie-José Frossard; Christophe Boissard; Santiago Fraga; Sylvain Bieler; Thomas Ruckle; Francis Vilbois; Sandra M Robinson; Manfred Mutter; William A Banks; Claudio Soto
Journal:  J Biol Chem       Date:  2003-02-10       Impact factor: 5.157

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 9.  Causative and susceptibility genes for Alzheimer's disease: a review.

Authors:  A Rocchi; S Pellegrini; G Siciliano; L Murri
Journal:  Brain Res Bull       Date:  2003-06-30       Impact factor: 4.077

10.  A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

Authors:  Takami Tomiyama; Tetsu Nagata; Hiroyuki Shimada; Rie Teraoka; Akiko Fukushima; Hyoue Kanemitsu; Hiroshi Takuma; Ryozo Kuwano; Masaki Imagawa; Suzuka Ataka; Yasuhiro Wada; Eito Yoshioka; Tomoyuki Nishizaki; Yasuyoshi Watanabe; Hiroshi Mori
Journal:  Ann Neurol       Date:  2008-03       Impact factor: 10.422

View more
  147 in total

1.  Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients.

Authors:  Ebba Lohmann; Rita J Guerreiro; Nihan Erginel-Unaltuna; Nicole Gurunlian; Basar Bilgic; Hakan Gurvit; Hasmet A Hanagasi; Nga Luu; Murat Emre; Andrew Singleton
Journal:  Neurobiol Aging       Date:  2012-04-13       Impact factor: 4.673

Review 2.  Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?

Authors:  Daniela Puzzo; Ottavio Arancio
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 3.  Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

4.  Functional analyses of variants reveal a significant role for dominant negative and common alleles in oligogenic Bardet-Biedl syndrome.

Authors:  Norann A Zaghloul; Yangjian Liu; Jantje M Gerdes; Cecilia Gascue; Edwin C Oh; Carmen C Leitch; Yana Bromberg; Jonathan Binkley; Rudolph L Leibel; Arend Sidow; Jose L Badano; Nicholas Katsanis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

5.  Amyloid precursor protein gene (APP) variation in late-onset Alzheimer's disease.

Authors:  Ana Miar; Victoria Alvarez; Ana I Corao; Marta Díaz; Belén Alonso; Carmen Martínez; María T Calatayud; Manuel Menéndez; Germán Morís; Eliecer Coto
Journal:  J Mol Neurosci       Date:  2011-03-22       Impact factor: 3.444

6.  Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide.

Authors:  Asa Hatami; Sanaz Monjazeb; Saskia Milton; Charles G Glabe
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

7.  Autosomal recessive causes likely in early-onset Alzheimer disease.

Authors:  Thomas S Wingo; James J Lah; Allan I Levey; David J Cutler
Journal:  Arch Neurol       Date:  2011-09-12

8.  Crucial role of nonspecific interactions in amyloid nucleation.

Authors:  Anđela Šarić; Yassmine C Chebaro; Tuomas P J Knowles; Daan Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

Review 9.  Targeting the β secretase BACE1 for Alzheimer's disease therapy.

Authors:  Riqiang Yan; Robert Vassar
Journal:  Lancet Neurol       Date:  2014-02-17       Impact factor: 44.182

Review 10.  Current status on Alzheimer disease molecular genetics: from past, to present, to future.

Authors:  Karolien Bettens; Kristel Sleegers; Christine Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2010-04-13       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.